Product Name

  • Name

    3,3-Dimethyl-D(-)-cysteine

  • EINECS 200-148-8
  • CAS No. 52-67-5
  • Article Data44
  • CAS DataBase
  • Density 1.205 g/cm3
  • Solubility 11.1 g/100 mL (20 ºC)
  • Melting Point 210 °C (dec.)(lit.)
  • Formula C5H11NO2S
  • Boiling Point 251.772 °C at 760 mmHg
  • Molecular Weight 149.214
  • Flash Point 106.068 °C
  • Transport Information
  • Appearance white powder
  • Safety 26-36-24/25-22
  • Risk Codes 36/37/38-40-20/21/22
  • Molecular Structure Molecular Structure of 52-67-5 (3,3-Dimethyl-D(-)-cysteine)
  • Hazard Symbols Xi,T,Xn
  • Synonyms Valine,3-mercapto-, D- (8CI);(-)-Penicillamine;(2S)-2-Amino-3-methyl-3-sulfanylbutanoic acid;(S)-3,3-Dimethylcysteine;(S)-Penicillamine;2-Amino-3-mercapto-3-methylbutanoic acid;Cuprenil;Cuprimine;Cupripen;D-3-Mercaptovaline;D-Mercaptovaline;D-Penamine;D-Penicillamine;DPA;Depamine;Depen;Kuprenil;Mercaptyl;Metalcaptase;NSC 81549;Pendramine;Penicillamin;Penicillamine;Perdolat;Reduced D-penicillamine;Reduced penicillamine;Sufirtan;Trolovol;b-Thiovaline;H-D-Pen-OH;
  • PSA 102.12000
  • LogP 0.80700

Synthetic route

benzylpenicillin potassium salt
113-98-4, 21794-94-5, 68244-03-1

benzylpenicillin potassium salt

p-toluidine
106-49-0

p-toluidine

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

(Z)-N-(p-methylphenyl)-3-(p-methylanilino)-2-(2-phenylacetamido)acrylamide
124827-15-2

(Z)-N-(p-methylphenyl)-3-(p-methylanilino)-2-(2-phenylacetamido)acrylamide

Conditions
ConditionsYield
With acetic acid In water; toluene for 5h; Ambient temperature; Heating;A 71%
B 95%
2-amino-benzenethiol
137-07-5

2-amino-benzenethiol

(5R,3S)-benzyl-D-penilloic acid
73184-06-2

(5R,3S)-benzyl-D-penilloic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

2-(1-phenylacetylaminomethyl)-2,3-dihydrobenzothiazole

2-(1-phenylacetylaminomethyl)-2,3-dihydrobenzothiazole

Conditions
ConditionsYield
With acetic acid In water 1.) reflux, 2 h, 2.) room temperature, 1 h;A 86%
B 93%
naphthalene-1,8-diamine
479-27-6

naphthalene-1,8-diamine

(5R,3S)-benzyl-D-penilloic acid
73184-06-2

(5R,3S)-benzyl-D-penilloic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

2-(1-phenylacetylaminomethyl)-2,3-dihydro-1H-perimidine

2-(1-phenylacetylaminomethyl)-2,3-dihydro-1H-perimidine

Conditions
ConditionsYield
With acetic acid In water for 2h; Heating;A 93%
B 87%
(5R,3S)-benzyl-D-penilloic acid
73184-06-2

(5R,3S)-benzyl-D-penilloic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

2-(1-phenylacetylaminomethyl)-2,3-dihydro-1H-perimidine

2-(1-phenylacetylaminomethyl)-2,3-dihydro-1H-perimidine

Conditions
ConditionsYield
With acetic acid; naphthalene-1,8-diamine In water for 2h; Heating;A 93%
B 87%
benzylpenicilloic acid α-phenylethylamide
121766-89-0

benzylpenicilloic acid α-phenylethylamide

A

benzoimidazole
51-17-2

benzoimidazole

B

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

C

phenaceturic acid α-phenethylamide
102016-26-2

phenaceturic acid α-phenethylamide

Conditions
ConditionsYield
With 1,2-diamino-benzene In water; acetic acid for 1.5h; Heating;A 59%
B 87%
C 91%
benzylpenicilloic acid α-phenylethylamide
121766-89-0

benzylpenicilloic acid α-phenylethylamide

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

A

benzoimidazole
51-17-2

benzoimidazole

B

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

C

phenaceturic acid α-phenethylamide
102016-26-2

phenaceturic acid α-phenethylamide

Conditions
ConditionsYield
In water; acetic acid for 1.5h; Heating;A 59%
B 87%
C 91%
benzylpenicilloic acid α-phenylethylamide
121766-89-0

benzylpenicilloic acid α-phenylethylamide

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

N-phenethyl-α-phenylacetamido-2-benzothiazolidineacetamide
121766-91-4, 121842-57-7

N-phenethyl-α-phenylacetamido-2-benzothiazolidineacetamide

Conditions
ConditionsYield
With 2-amino-benzenethiol In water; acetic acid for 2h; Heating;A 83%
B 89%
benzylpenicilloic acid α-phenylethylamide
121766-89-0

benzylpenicilloic acid α-phenylethylamide

2-amino-benzenethiol
137-07-5

2-amino-benzenethiol

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

N-phenethyl-α-phenylacetamido-2-benzothiazolidineacetamide
121766-91-4, 121842-57-7

N-phenethyl-α-phenylacetamido-2-benzothiazolidineacetamide

Conditions
ConditionsYield
In water; acetic acid for 2h; Heating;A 83%
B 89%
benzylpenicilloic acid α-anilide
121766-90-3

benzylpenicilloic acid α-anilide

A

benzoimidazole
51-17-2

benzoimidazole

B

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

C

N-phenyl-N2-(phenylacetyl)glycinamide
15440-35-4

N-phenyl-N2-(phenylacetyl)glycinamide

Conditions
ConditionsYield
With 1,2-diamino-benzene In water; acetic acid for 1.5h; Heating;A 58%
B 86%
C 81%
2-amino-benzenethiol
137-07-5

2-amino-benzenethiol

<2R-<2α(R*),4β>>-5,5-dimethyl-2-<2-oxo-1-<(phenylacetyl)amino>-2-<(phenylmethyl)amino>ethyl>-4-thiazolidinecarboxylic acid
66317-00-8

<2R-<2α(R*),4β>>-5,5-dimethyl-2-<2-oxo-1-<(phenylacetyl)amino>-2-<(phenylmethyl)amino>ethyl>-4-thiazolidinecarboxylic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

N-Benzyl-2-(2,3-dihydro-benzothiazol-2-yl)-2-phenylacetylamino-acetamide
121766-92-5, 121767-02-0

N-Benzyl-2-(2,3-dihydro-benzothiazol-2-yl)-2-phenylacetylamino-acetamide

Conditions
ConditionsYield
In water; acetic acid for 2h; Heating;A 81%
B 86%
<2R-<2α(R*),4β>>-5,5-dimethyl-2-<2-oxo-1-<(phenylacetyl)amino>-2-<(phenylmethyl)amino>ethyl>-4-thiazolidinecarboxylic acid
66317-00-8

<2R-<2α(R*),4β>>-5,5-dimethyl-2-<2-oxo-1-<(phenylacetyl)amino>-2-<(phenylmethyl)amino>ethyl>-4-thiazolidinecarboxylic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

N-Benzyl-2-(2,3-dihydro-benzothiazol-2-yl)-2-phenylacetylamino-acetamide
121766-92-5, 121767-02-0

N-Benzyl-2-(2,3-dihydro-benzothiazol-2-yl)-2-phenylacetylamino-acetamide

Conditions
ConditionsYield
With 2-amino-benzenethiol In water; acetic acid for 2h; Heating;A 81%
B 86%
<2R-<2α(R*),4β>>-5,5-dimethyl-2-<2-oxo-1-<(phenylacetyl)amino>-2-<(phenylmethyl)amino>ethyl>-4-thiazolidinecarboxylic acid
66317-00-8

<2R-<2α(R*),4β>>-5,5-dimethyl-2-<2-oxo-1-<(phenylacetyl)amino>-2-<(phenylmethyl)amino>ethyl>-4-thiazolidinecarboxylic acid

A

benzoimidazole
51-17-2

benzoimidazole

B

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

C

N-benzyl-2-(2-phenylacetamido)acetamide
15440-34-3

N-benzyl-2-(2-phenylacetamido)acetamide

Conditions
ConditionsYield
With 1,2-diamino-benzene In water; acetic acid for 1.5h; Heating;A 57%
B 80%
C 85%
benzylpenicilloic acid α-phenylethylamide
121766-89-0

benzylpenicilloic acid α-phenylethylamide

naphthalene-1,8-diamine
479-27-6

naphthalene-1,8-diamine

A

1-H-perimidine
204-02-4

1-H-perimidine

B

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

C

phenaceturic acid α-phenethylamide
102016-26-2

phenaceturic acid α-phenethylamide

Conditions
ConditionsYield
In water; acetic acid for 2h; Heating;A 85%
B 69%
C 74%
(S)-2-tert-butoxyamide-3-methyl-3-thioacetoxybutyric acid

(S)-2-tert-butoxyamide-3-methyl-3-thioacetoxybutyric acid

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

Conditions
ConditionsYield
Stage #1: (S)-2-tert-butoxyamide-3-methyl-3-thioacetoxybutyric acid With hydrogenchloride In 1,4-dioxane; water at 0℃; Reflux;
Stage #2: With pyridine In ethanol
81%
<2R-<2α(R*),4β>>-2-<2-(ethylamino)-2-oxo-1-<(phenylacetyl)amino>ethyl>-5,5-dimethyl-4-thiazolidinecarboxylic acid
66317-01-9

<2R-<2α(R*),4β>>-2-<2-(ethylamino)-2-oxo-1-<(phenylacetyl)amino>ethyl>-5,5-dimethyl-4-thiazolidinecarboxylic acid

A

benzoimidazole
51-17-2

benzoimidazole

B

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

C

N-phenylacetyl-glycine ethylamide
25443-71-4

N-phenylacetyl-glycine ethylamide

Conditions
ConditionsYield
With 1,2-diamino-benzene In water; acetic acid for 1.5h; Heating;A 55%
B 71%
C 79%
<2R-<2α(R*),4β>>-2-<2-(ethylamino)-2-oxo-1-<(phenylacetyl)amino>ethyl>-5,5-dimethyl-4-thiazolidinecarboxylic acid
66317-01-9

<2R-<2α(R*),4β>>-2-<2-(ethylamino)-2-oxo-1-<(phenylacetyl)amino>ethyl>-5,5-dimethyl-4-thiazolidinecarboxylic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

2-(2,3-Dihydro-benzothiazol-2-yl)-N-ethyl-2-phenylacetylamino-acetamide
121766-94-7, 121767-04-2

2-(2,3-Dihydro-benzothiazol-2-yl)-N-ethyl-2-phenylacetylamino-acetamide

Conditions
ConditionsYield
With 2-amino-benzenethiol In water; acetic acid for 2h; Heating;A 74%
B 79%
<2R-<2α(R*),4β>>-2-<2-(ethylamino)-2-oxo-1-<(phenylacetyl)amino>ethyl>-5,5-dimethyl-4-thiazolidinecarboxylic acid
66317-01-9

<2R-<2α(R*),4β>>-2-<2-(ethylamino)-2-oxo-1-<(phenylacetyl)amino>ethyl>-5,5-dimethyl-4-thiazolidinecarboxylic acid

2-amino-benzenethiol
137-07-5

2-amino-benzenethiol

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

2-(2,3-Dihydro-benzothiazol-2-yl)-N-ethyl-2-phenylacetylamino-acetamide
121766-94-7, 121767-04-2

2-(2,3-Dihydro-benzothiazol-2-yl)-N-ethyl-2-phenylacetylamino-acetamide

Conditions
ConditionsYield
In water; acetic acid for 2h; Heating;A 74%
B 79%
aniline
62-53-3

aniline

(5R,3S)-benzyl-D-penilloic acid
73184-06-2

(5R,3S)-benzyl-D-penilloic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

(2R*,3R*,4S*)-3-phenylacetylamino-2-phenylacetylaminomethyl-4-phenylamino-1,2,3,4-tetrahydroquinoline

(2R*,3R*,4S*)-3-phenylacetylamino-2-phenylacetylaminomethyl-4-phenylamino-1,2,3,4-tetrahydroquinoline

(2R*,3S*,4R*)-3-phenylacetylamino-2-phenylacetylaminomethyl-4-phenylamino-1,2,3,4-tetrahydroquinoline

(2R*,3S*,4R*)-3-phenylacetylamino-2-phenylacetylaminomethyl-4-phenylamino-1,2,3,4-tetrahydroquinoline

Conditions
ConditionsYield
With acetic acid In water; toluene for 4h; Heating;A 79%
B 9%
C 7%
N,N'-diphenylethylenediamine
150-61-8

N,N'-diphenylethylenediamine

(S)-5,5-Dimethyl-2-((R)-phenethylcarbamoyl-phenylacetylamino-methyl)-thiazolidine-4-carboxylic acid

(S)-5,5-Dimethyl-2-((R)-phenethylcarbamoyl-phenylacetylamino-methyl)-thiazolidine-4-carboxylic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

N-formyl-N,N'-diphenylethylenediamine
55055-34-0

N-formyl-N,N'-diphenylethylenediamine

C

phenaceturic acid α-phenethylamide
102016-26-2

phenaceturic acid α-phenethylamide

Conditions
ConditionsYield
In acetic acid Heating;A 51%
B 63%
C 76%
In acetic acid for 5h; Mechanism; Heating; var. penicilloic acid α-amides;A 51%
B 63%
C 76%
(S)-5,5-Dimethyl-2-((R)-phenethylcarbamoyl-phenylacetylamino-methyl)-thiazolidine-4-carboxylic acid

(S)-5,5-Dimethyl-2-((R)-phenethylcarbamoyl-phenylacetylamino-methyl)-thiazolidine-4-carboxylic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

phenaceturic acid α-phenethylamide
102016-26-2

phenaceturic acid α-phenethylamide

Conditions
ConditionsYield
With N,N'-diphenylethylenediamine In acetic acid for 5h; Heating;A 51%
B 76%
(S)-5,5-Dimethyl-2-((R)-phenylacetylamino-phenylcarbamoyl-methyl)-thiazolidine-4-carboxylic acid

(S)-5,5-Dimethyl-2-((R)-phenylacetylamino-phenylcarbamoyl-methyl)-thiazolidine-4-carboxylic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

N-phenyl-N2-(phenylacetyl)glycinamide
15440-35-4

N-phenyl-N2-(phenylacetyl)glycinamide

Conditions
ConditionsYield
With N,N'-diphenylethylenediamine In acetic acid Heating;A 49%
B 75%
acid α-phenethylamide

acid α-phenethylamide

4-chloro-aniline
106-47-8

4-chloro-aniline

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

Conditions
ConditionsYield
With acetic acid In methanol; water73.2%
(S)-2-((R)-Benzylcarbamoyl-phenylacetylamino-methyl)-5,5-dimethyl-thiazolidine-4-carboxylic acid

(S)-2-((R)-Benzylcarbamoyl-phenylacetylamino-methyl)-5,5-dimethyl-thiazolidine-4-carboxylic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

N-benzyl-2-(2-phenylacetamido)acetamide
15440-34-3

N-benzyl-2-(2-phenylacetamido)acetamide

Conditions
ConditionsYield
With N,N'-diphenylethylenediamine In acetic acid Heating;A 47%
B 72%
4-methoxy-aniline
104-94-9

4-methoxy-aniline

benzylpenicilloic acid α-phenylethylamide
121766-89-0

benzylpenicilloic acid α-phenylethylamide

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

3-[(E)-4-Methoxy-phenylimino]-N-phenethyl-2-phenylacetylamino-propionamide

3-[(E)-4-Methoxy-phenylimino]-N-phenethyl-2-phenylacetylamino-propionamide

Conditions
ConditionsYield
In water; acetic acid; toluene Heating;A 71%
B n/a
benzylpenicilloic acid α-anilide
121766-90-3

benzylpenicilloic acid α-anilide

2-amino-benzenethiol
137-07-5

2-amino-benzenethiol

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

2-(2,3-Dihydro-benzothiazol-2-yl)-N-phenyl-2-phenylacetylamino-acetamide
121766-93-6, 121767-03-1

2-(2,3-Dihydro-benzothiazol-2-yl)-N-phenyl-2-phenylacetylamino-acetamide

Conditions
ConditionsYield
In water; acetic acid for 2h; Heating;A 71%
B 68%
benzylpenicilloic acid α-anilide
121766-90-3

benzylpenicilloic acid α-anilide

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

2-(2,3-Dihydro-benzothiazol-2-yl)-N-phenyl-2-phenylacetylamino-acetamide
121766-93-6, 121767-03-1

2-(2,3-Dihydro-benzothiazol-2-yl)-N-phenyl-2-phenylacetylamino-acetamide

Conditions
ConditionsYield
With 2-amino-benzenethiol In water; acetic acid for 2h; Heating;A 71%
B 68%
(S)-2-((R)-Ethylcarbamoyl-phenylacetylamino-methyl)-5,5-dimethyl-thiazolidine-4-carboxylic acid

(S)-2-((R)-Ethylcarbamoyl-phenylacetylamino-methyl)-5,5-dimethyl-thiazolidine-4-carboxylic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

N-phenylacetyl-glycine ethylamide
25443-71-4

N-phenylacetyl-glycine ethylamide

Conditions
ConditionsYield
With N,N'-diphenylethylenediamine In acetic acid Heating;A 42%
B 71%
(S)-5,5-Dimethyl-2-[(R)-phenethylcarbamoyl-(2-phenoxy-acetylamino)-methyl]-thiazolidine-4-carboxylic acid

(S)-5,5-Dimethyl-2-[(R)-phenethylcarbamoyl-(2-phenoxy-acetylamino)-methyl]-thiazolidine-4-carboxylic acid

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

N-phenoxy-acetylglycine α-phenethylamide

N-phenoxy-acetylglycine α-phenethylamide

Conditions
ConditionsYield
With N,N'-diphenylethylenediamine In acetic acid Heating;A 47%
B 69%
p-toluidine
106-49-0

p-toluidine

benzylpenicilloic acid α-phenylethylamide
121766-89-0

benzylpenicilloic acid α-phenylethylamide

A

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

B

N-Phenethyl-2-phenylacetylamino-3-[(E)-p-tolylimino]-propionamide

N-Phenethyl-2-phenylacetylamino-3-[(E)-p-tolylimino]-propionamide

Conditions
ConditionsYield
In water; acetic acid; toluene Heating;A 68%
B n/a
formaldehyd
50-00-0

formaldehyd

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

(S)-1-aza-3-oxa-7-thiabicyclo[3.30]-6-dimethyloctan-4-one

(S)-1-aza-3-oxa-7-thiabicyclo[3.30]-6-dimethyloctan-4-one

Conditions
ConditionsYield
With magnesium sulfate In dichloromethane for 168h; Ambient temperature;100%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

2-Bromoethyl methyl ether
6482-24-2

2-Bromoethyl methyl ether

(2S)-2-((tert-butoxycarbonyl)amino)-3-((2-methoxyethyl)thio)-3-methylbutanoic acid
856417-53-3

(2S)-2-((tert-butoxycarbonyl)amino)-3-((2-methoxyethyl)thio)-3-methylbutanoic acid

Conditions
ConditionsYield
Stage #1: 3,3-dimethyl-D-cysteine; di-tert-butyl dicarbonate; 2-Bromoethyl methyl ether With sodium hydroxide; ethanol at 0 - 20℃; for 15h;
Stage #2: di-tert-butyl dicarbonate With sodium hydroxide; water at 20℃; for 15h;
100%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

methyl iodide
74-88-4

methyl iodide

S-methyl D-penicillamine
29913-84-6

S-methyl D-penicillamine

Conditions
ConditionsYield
With sodium hydride In methanol at 20℃; Inert atmosphere;99%
With sodium hydride In methanol at 20℃; Inert atmosphere;99%
methanol
67-56-1

methanol

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

D-penicillamine methyl ester hydrochloride
34297-27-3

D-penicillamine methyl ester hydrochloride

Conditions
ConditionsYield
With hydrogenchloride at 20℃;98%
With hydrogenchloride at 20℃;98%
With thionyl chloride at 0 - 20℃; for 48.5h;91%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

Boc-D-Pen-OH
119222-62-7

Boc-D-Pen-OH

Conditions
ConditionsYield
With sodium hydroxide In ethyl acetate; tert-butyl alcohol98%
With sodium hydroxide In tert-butyl alcohol at 20℃;
1,3-bis(diphenylphosphino)propane digold(I) dichloride
72428-60-5

1,3-bis(diphenylphosphino)propane digold(I) dichloride

ethanol
64-17-5

ethanol

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

water
7732-18-5

water

C37H46Au2N2O4P2S2*C2H6O*3H2O

C37H46Au2N2O4P2S2*C2H6O*3H2O

Conditions
ConditionsYield
With sodium hydroxide at 20℃; for 2h;97%
formaldehyd
50-00-0

formaldehyd

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

(S)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
22916-26-3

(S)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid

Conditions
ConditionsYield
In ethanol; water at 20℃; for 18h;96%
In water at 0 - 20℃; for 23h;81%
With pyridine In ethanol; water at 110℃; for 0.0833333h; Microwave irradiation;76%
bismuth (III) oxychloride

bismuth (III) oxychloride

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

{D-(-)-penicillaminato-O,S,N}bismuth(III) chloride

{D-(-)-penicillaminato-O,S,N}bismuth(III) chloride

Conditions
ConditionsYield
In water stirring of BiOCl into a soln. of D-(-)-penicillamine in water at 40°C; stirring for 15 min at 40°C; filtration;; crystallization on storing at room temperature; washing with cold water; drying; elem. anal.;;96%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

D-Val-OH
640-68-6

D-Val-OH

Conditions
ConditionsYield
With [4,4’-bis(1,1-dimethylethyl)-2,2’-bipyridine-N1,N1‘]bis [3,5-difluoro-2-[5-(trifluoromethyl)-2-pyridinyl-N]phenyl-C]iridium(III) hexafluorophosphate; triethyl phosphite In aq. phosphate buffer; acetonitrile at 20℃; for 0.5h; pH=6.5; Irradiation;96%
bis(triphenylphosphine)iminium gold(I) bis(acetylide)

bis(triphenylphosphine)iminium gold(I) bis(acetylide)

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

bis(triphenylphosphoranylidene)ammonium bis(D-penicillaminato-S)aurate(I)

bis(triphenylphosphoranylidene)ammonium bis(D-penicillaminato-S)aurate(I)

Conditions
ConditionsYield
In dichloromethane byproducts: acetylacetone; N2-atmosphere; dropwise addn. of Au-complex soln. to 2 equiv. of ligand soln. (room temp.), stirring (1 h); filtration (Celite), concn., pptn. on Et2O addn., filtration, recrystn. (CH2Cl2/Et2O), drying (vac.); elem. anal.;95%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

water
7732-18-5

water

silver nitrate

silver nitrate

Ag[D-penicillamine]*H2O

Ag[D-penicillamine]*H2O

Conditions
ConditionsYield
With KOH In potassium hydroxide aq. KOH; AgNO3 soln. (pH 5) added to alkaline soln. of penicillamine; solid filtered, washed (EtOH), dried (P4O10); elem. anal.;95%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

water
7732-18-5

water

potassium dicyanoaurate

potassium dicyanoaurate

Au[D-penicillamine]*H2O

Au[D-penicillamine]*H2O

Conditions
ConditionsYield
With KOH; HCl In water aurate soln. (pH 5) added to alkaline soln. of penicillamine, pH 9, thenHCl added dropwise, final pH 4; solid filtered, washed (EtOH), dried (P4O10); elem. anal.;95%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

(tetrahydrothiophene)gold(I) chloride

(tetrahydrothiophene)gold(I) chloride

water
7732-18-5

water

bis-diphenylphosphinomethane
2071-20-7

bis-diphenylphosphinomethane

[trigold(I)(bis(diphenylphosphino)methane)2(D-Hpenicillaminate)(D-penicillaminate)]*10H2O

[trigold(I)(bis(diphenylphosphino)methane)2(D-Hpenicillaminate)(D-penicillaminate)]*10H2O

Conditions
ConditionsYield
Stage #1: 3,3-dimethyl-D-cysteine; tetrahydrothiophene gold(I)chloride; bis-diphenylphosphinomethane In ethanol; dichloromethane at 20℃; for 1h; Darkness;
Stage #2: With sodium hydroxide In ethanol; dichloromethane
Stage #3: water In methanol at 20℃; for 840h;
95%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

[(μ-bis(diphenylphosphino)ethane)Au2Cl2]

[(μ-bis(diphenylphosphino)ethane)Au2Cl2]

water
7732-18-5

water

[Au2(1,2-bis(diphenylphosphino)ethane)(L-Hpenicillaminate)2]*9H2O

[Au2(1,2-bis(diphenylphosphino)ethane)(L-Hpenicillaminate)2]*9H2O

Conditions
ConditionsYield
With potassium hydroxide In ethanol at 20℃; for 2h;95%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

terephthalaldehyde,
623-27-8

terephthalaldehyde,

C18H24N2O4S2
124652-16-0

C18H24N2O4S2

Conditions
ConditionsYield
In methanol; water for 4h; Ambient temperature;93%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

2,4-Dinitrofluorobenzene
70-34-8

2,4-Dinitrofluorobenzene

1-Fluoro-2,4-dinitro-benzene; compound with (S)-2-amino-3-mercapto-3-methyl-butyric acid

1-Fluoro-2,4-dinitro-benzene; compound with (S)-2-amino-3-mercapto-3-methyl-butyric acid

Conditions
ConditionsYield
With hydrogenchloride; sodium hydrogencarbonate In water at 70℃; for 0.75h;91.8%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

acetone
67-64-1

acetone

(4S)-2,2,5,5-tetramethylthiazolidine-4-carboxylic acid
72744-87-7

(4S)-2,2,5,5-tetramethylthiazolidine-4-carboxylic acid

Conditions
ConditionsYield
at 55℃; for 2h;91.2%
for 2h; Condensation; Heating;90%
In water88%
In water for 15h; Ambient temperature;70%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

opianic acid
519-05-1

opianic acid

(3S,10R)-2,3,5,10-Tetrahydro-6,7-dimethoxy-2,2-dimethyl-5-oxo-<1,3>-thiazolo<2,3-a>isoindol-3-carbonsaeure
97272-80-5

(3S,10R)-2,3,5,10-Tetrahydro-6,7-dimethoxy-2,2-dimethyl-5-oxo-<1,3>-thiazolo<2,3-a>isoindol-3-carbonsaeure

Conditions
ConditionsYield
In water for 1h; Heating;91%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

2-bromomethylnaphthyl bromide
939-26-4

2-bromomethylnaphthyl bromide

C16H19NO2S
1256761-30-4

C16H19NO2S

Conditions
ConditionsYield
With N,N,N',N'-tetramethylguanidine In tetrahydrofuran at 50℃; for 1h; Inert atmosphere;91%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

N-methyl2-piperidone diethyl acetal
37128-99-7

N-methyl2-piperidone diethyl acetal

(S)-3-Mercapto-3-methyl-2-[1-methyl-piperidin-(2E)-ylideneamino]-butyric acid
105099-13-6, 122861-60-3

(S)-3-Mercapto-3-methyl-2-[1-methyl-piperidin-(2E)-ylideneamino]-butyric acid

Conditions
ConditionsYield
In ethanol at 20 - 25℃; for 5h;90%
3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

phenylglyoxal hydrate
1074-12-0

phenylglyoxal hydrate

2-benzoyl-5,5-dimethyl-thiazolidine-4-carboxylic acid

2-benzoyl-5,5-dimethyl-thiazolidine-4-carboxylic acid

Conditions
ConditionsYield
In phosphate buffer; water at 20℃; for 0.666667h; pH=7.4;90%
In phosphate buffer at 37℃; pH=7.4; Product distribution; Kinetics;
pyrrolidine
123-75-1

pyrrolidine

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

A

4-carboxy-2,5,5-trimethylthiazolidine-2-acetopyrrolidide

4-carboxy-2,5,5-trimethylthiazolidine-2-acetopyrrolidide

B

hexane
110-54-3

hexane

Conditions
ConditionsYield
In benzeneA 90%
B n/a
[(ClAu)]3(1,1,1-tris(diphenylphosphinomethyl)ethane)
84152-18-1

[(ClAu)]3(1,1,1-tris(diphenylphosphinomethyl)ethane)

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

water
7732-18-5

water

[Au3(1,1,1-tris(diphenylphosphinomethyl)ethane)(D-Hpenicillamine)3]*5H2O

[Au3(1,1,1-tris(diphenylphosphinomethyl)ethane)(D-Hpenicillamine)3]*5H2O

Conditions
ConditionsYield
In ethanol at 20℃; for 1h;90%
4-butynyloxybenzenesulfonyl chloride

4-butynyloxybenzenesulfonyl chloride

3,3-dimethyl-D-cysteine
52-67-5

3,3-dimethyl-D-cysteine

2-bromoethanol
540-51-2

2-bromoethanol

N-{[4-(2 butynyloxy)phenyl]-sulfonyl}-3-[(2-hydroxyethyl)sulfanyl]valine

N-{[4-(2 butynyloxy)phenyl]-sulfonyl}-3-[(2-hydroxyethyl)sulfanyl]valine

Conditions
ConditionsYield
With sodium hydroxide; sodium carbonate In methanol; water; N,N-dimethyl-formamide89.6%

D-(-)-Penicillamine Specification

The D,3-Mercaptovaline with CAS registry number of 52-67-5 is also called D-Valine, 3-mercapto-. The IUPAC name is (2S)-2-amino-3-methyl-3-sulfanylbutanoic acid. Its EINECS registry number is 200-148-8. In addition, the molecular formula is C5H11NO2S and the molecular weight is 149.21. It is a kind of white to off-white crystalline powder and belongs to the classes of Amino Acids; Biochemistry; non-Proteinorganic Amino Acids; Miscellaneous Compounds; Antibiotics. And it is stable and incompatible with strong oxidizing agents.

Physical properties about this chemical are: (1)ACD/LogP: 0.85; (2)# of Rule of 5 Violations: 0 ; (3)ACD/BCF (pH 5.5): 1; (4)ACD/BCF (pH 7.4): 1; (5)ACD/KOC (pH 5.5): 1; (6)ACD/KOC (pH 7.4): 1; (7)#H bond acceptors: 3; (8)#H bond donors: 3; (9)#Freely Rotating Bonds: 4; (10)Polar Surface Area: 102.12 Å2; (11)Index of Refraction: 1.528; (12)Molar Refractivity: 38.134 cm3; (13)Molar Volume: 123.845 cm3; (14)Polarizability: 15.117 ×10-24cm3; (15)Surface Tension: 48.155 dyne/cm; (16)Density: 1.205 g/cm3; (17)Flash Point: 106.068 °C; (18)Enthalpy of Vaporization: 53.854 kJ/mol; (19)Boiling Point: 251.772 °C at 760 mmHg; (20)Vapour Pressure: 0.006 mmHg at 25°C.

Preparation of D,3-Mercaptovaline: it can be prepared by penicillin through synthesis or degradation. It also can be prepared by penicillin G potassium by means of hydrolysis.

Uses of D,3-Mercaptovaline: it can be used as antidoteit of some heavy metals such as copper and mercury. And it can be used in the treatment of Wilson's disease and rheumatoid arthritis. It does not apply to the hematopoiesis function obstacle patients, kidney function decline patients and who allergic to penicillin. In addition, it can react with formic acid to get N-formyl-penicillamine. This reaction will need reagent acetic anhydride. The reaction time is 3 hours at ambient temperature. The yield is about 78%.

D,3-Mercaptovaline can reacr with formic acid to get N-formyl-penicillamine

When you are using this chemical, please be cautious about it as the following:
This chemical is irritating to eyes, respiratory system and skin and harmful by inhalation, in contact with skin and if swallowed. The evidence of a carcinogenic effect is limited. During using it, do not breathe dust and wear suitable protective clothing. Moreover, avoid contact with skin and eyes. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
(1)SMILES: CC(C)([C@H](C(=O)O)N)S
(2)InChI: InChI=1/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m0/s1
(3)InChIKey: VVNCNSJFMMFHPL-VKHMYHEABH

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
child TDLo oral 40mg/kg/1W-I (40mg/kg) BLOOD: LEUKOPENIA

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
Archives of Internal Medicine. Vol. 145, Pg. 2271, 1985.
human TDLo oral 21mg/kg/D (21mg/kg) KIDNEY, URETER, AND BLADDER: PROTEINURIS

BLOOD: LEUKOPENIA

BLOOD: THROMBOCYTOPENIA
JAMA, Journal of the American Medical Association. Vol. 240, Pg. 1870, 1978.
human TDLo oral 893mg/kg/30W- (893mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

MUSCULOSKELETAL: OTHER CHANGES
Journal of Rheumatology. Vol. 11, Pg. 251, 1984.
man TDLo oral 400mg/kg/4W-I (400mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BLOOD: HEMORRHAGE
Journal of Rheumatology. Vol. 13, Pg. 963, 1986.
man TDLo oral 482mg/kg/19W- (482mg/kg) BLOOD: THROMBOCYTOPENIA

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
Archives of Internal Medicine. Vol. 143, Pg. 1487, 1983.
man TDLo unreported 3200mg/kg/84W (3200mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
British Medical Journal. Vol. 296, Pg. 1332, 1988.
mouse LD50 intraperitoneal 298mg/kg (298mg/kg)   Yakugaku Zasshi. Journal of Pharmacy. Vol. 94, Pg. 1419, 1974.
mouse LD50 intravenous 3840mg/kg (3840mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 162, 1975.
mouse LD50 oral 720mg/kg (720mg/kg)   Pharmaceutical Chemistry Journal Vol. 21, Pg. 842, 1987.
mouse LD50 subcutaneous 3810mg/kg (3810mg/kg)   Drugs in Japan Vol. 6, Pg. 758, 1982.
rat LD50 intraperitoneal 2080mg/kg (2080mg/kg)   Drugs in Japan Vol. 6, Pg. 758, 1982.
rat LD50 intravenous 2gm/kg (2000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 22, Pg. 1434, 1972.
rat LD50 oral 6170mg/kg (6170mg/kg)   Drugs in Japan Vol. 6, Pg. 758, 1982.
rat LD50 subcutaneous 4020mg/kg (4020mg/kg)   Drugs in Japan Vol. 6, Pg. 758, 1982.
women LDLo oral 150mg/kg/30D- (150mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Annals of Internal Medicine. Vol. 98, Pg. 327, 1983.
women TDLo oral 105mg/kg/6W-I (105mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" British Medical Journal. Vol. 294, Pg. 1101, 1987.
women TDLo oral 112mg/kg/1W-I (112mg/kg) BLOOD: AGRANULOCYTOSIS

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
Archives of Internal Medicine. Vol. 145, Pg. 2271, 1985.
women TDLo oral 900mg/kg/26W- (900mg/kg) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" Journal of Rheumatology. Vol. 12, Pg. 583, 1985.
women TDLo oral 650gm/kg/81W- (650000mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

MUSCULOSKELETAL: OTHER CHANGES
Arthritis and Rheumatism. Vol. 29, Pg. 560, 1986.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View